# The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or DCIS in Patients Diagnosed With Intraductal Papilloma Without Atypia or Flat Epithelial Atypia by Core Needle Biopsy

> **NCT02489617** · NA · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 246 (actual)

## Conditions studied

- Flat Epithelia Atypia
- Intraductal Papilloma Without Atypia

## Interventions

- **OTHER:** Pathologic evaluation of excised tissue

## Key facts

- **NCT ID:** NCT02489617
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2021-12
- **Final completion:** 2025-06
- **Target enrollment:** 246 (ACTUAL)
- **Last updated:** 2025-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02489617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02489617, "The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or DCIS in Patients Diagnosed With Intraductal Papilloma Without Atypia or Flat Epithelial Atypia by Core Needle Biopsy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02489617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*